[5-min read] Q&A with Ben Lightburn, CEO & Cofounder
[4-min read] Monash completes the fastest psychedelic trial of the modern era.
[5-min read] Q&A with Natalie Lyla Ginsberg, Global Impact Officer
[5-min read] Psilocybin retreat center publishes two years of clinical outcomes.
[5-min read] Q&A with Jennifer Chesak, Author & Journalist
[5-min read] Colorado drafts regulations for psychedelic facilitators.
[5-min read] Q&A with Robin Carhart-Harris, Researcher & Professor
[5-min read] First-ever study explores the effects of psychedelics on sexual function.
[6-min read] Q&A with Josh Hardman, Reporter & Consultant
[5-min read] MAPS invests in Numinus to scale MDMA-assisted therapy and training.
[5-min read] Q&A with Julia Reibelt, Strategist & Writer
[5-min read] Psychedelic therapy may be less influenced by expectancy than once thought.
